Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$859M |
| 2 |
Progressive
PGR
|
$429M |
| 3 |
Netflix
NFLX
|
$368M |
| 4 |
Danaher
DHR
|
$364M |
| 5 |
Adobe
ADBE
|
$343M |
Top Sells
| 1 |
Advanced Micro Devices
AMD
|
$710M |
| 2 |
Microsoft
MSFT
|
$619M |
| 3 |
NVIDIA
NVDA
|
$447M |
| 4 |
Eli Lilly
LLY
|
$391M |
| 5 |
AbbVie
ABBV
|
$373M |
Sector Composition
| 1 | Technology | 32.66% |
| 2 | Healthcare | 19.35% |
| 3 | Industrials | 10.04% |
| 4 | Financials | 10% |
| 5 | Consumer Discretionary | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Ryan Specialty Holdings
RYAN
$6.96B
| $153M | 0.1% |
3,405,955
+30,430
| +0.9% | +$1.37M |
|
202
Gilead Sciences
GILD
$143B
| $148M | 0.09% |
1,917,567
+310,811
| +19% | +$24M |
|
203
Visteon
VC
$3.41B
| $147M | 0.09% |
1,024,914
-22,949
| -2% | -$3.3M |
|
204
PTC Therapeutics
PTCT
$4.55B
| $146M | 0.09% |
3,596,750
+400,446
| +13% | +$16.3M |
|
205
Frontdoor
FTDR
$4.59B
| $146M | 0.09% |
4,577,840
+41,237
| +0.9% | +$1.32M |
|
206
Magnolia Oil & Gas
MGY
$4.38B
| $143M | 0.09% |
6,845,699
+151,767
| +2% | +$3.17M |
|
207
EnerSys
ENS
$3.89B
| $142M | 0.09% |
1,309,117
-1,083
| -0.1% | -$118K |
|
208
Vanguard Total International Stock ETF
VXUS
$102B
| $141M | 0.09% |
2,512,798
-25,879
| -1% | -$1.45M |
|
209
Applied Materials
AMAT
$130B
| $139M | 0.09% |
961,101
+68,127
| +8% | +$9.85M |
|
210
Salesforce
CRM
$239B
| $136M | 0.08% |
641,779
-23,641
| -4% | -$4.99M |
|
211
Marsh & McLennan
MMC
$100B
| $134M | 0.08% |
713,224
+27,847
| +4% | +$5.24M |
|
212
Rivian
RIVN
$17.2B
| $134M | 0.08% |
8,025,600
+1,493,926
| +23% | +$24.9M |
|
213
Capital One
COF
$142B
| $131M | 0.08% |
1,198,332
+9,838
| +0.8% | +$1.08M |
|
214
Williams Companies
WMB
$69.9B
| $130M | 0.08% |
3,996,855
+69,875
| +2% | +$2.28M |
|
215
Intuitive Surgical
ISRG
$167B
| $130M | 0.08% |
381,094
-9,754
| -2% | -$3.34M |
|
216
Mercado Libre
MELI
$123B
| $129M | 0.08% |
108,907
+11,102
| +11% | +$13.1M |
|
217
Biohaven
BHVN
$1.68B
| $127M | 0.08% |
5,316,799
+57,129
| +1% | +$1.37M |
|
218
Legend Biotech
LEGN
$6.66B
| $125M | 0.08% |
1,814,337
-124,754
| -6% | -$8.61M |
|
219
Axon Enterprise
AXON
$57.2B
| $125M | 0.08% |
641,478
-66,193
| -9% | -$12.9M |
|
220
Welltower
WELL
$112B
| $125M | 0.08% |
1,544,381
-234,704
| -13% | -$19M |
|
|
SUM
221
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $124M | 0.08% |
3,282,317
-1,676
| -0.1% | -$63.4K |
|
|
CHX
222
DELISTED
ChampionX
CHX
| $124M | 0.08% |
4,000,616
+1,476,800
| +59% | +$45.8M |
|
|
AVDL
223
Avadel Pharmaceuticals
AVDL
$1.53B
| $124M | 0.08% |
7,522,545
+695,758
| +10% | +$11.5M |
|
224
Organon & Co
OGN
$2.7B
| $124M | 0.08% |
5,952,407
-372,321
| -6% | -$7.75M |
|
225
Burlington
BURL
$18.4B
| $122M | 0.08% |
776,007
+5,175
| +0.7% | +$814K |
|